Simplifying First Trimester Medical Abortion Follow-up

Completed

• Conditions: Medical Abortion

• Registration Number: NCT03014193
• Lead Sponsor: Gynuity Health Projects

Brief Summary

This study evaluates the usability of the multilevel pregnancy test among women undergoing medical abortion.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01
• Study First Submitted: 2017-01-05
• Study First Submitted QC: 2017-01-05
• Study First Posted: 2017-01-09
• Primary Completion: 2017-07
• Study Completion: 2017-07
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-01
• Last Update Posted: 2017-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 250

Inclusion Criteria

• Have a first trimester pregnancy with a gestational age of ≤63 days;
• Desire medical abortion with mifepristone and misoprostol and be medically eligible for that treatment, according to clinic protocol;
• Be able to read and understand the local language or Russian;
• Have access to a telephone;
• Agree to follow all study procedures;
• Have no contraindication to participation in the study, in the judgment of the site investigator or designee.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Understanding of the instructions for the multilevel pregnancy test	14 days
Ability to independently use the multilevel pregnancy tests	14 days
Ability to interpret the results of the multilevel pregnancy test	14 days

Trial Locations

Locations (5)

Gyumri Maternity Hospital; 🇦🇲 Gyumri, Armenia

Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology; 🇦🇲 Yerevan, Armenia

Batumi International Hospital; 🇬🇪 Batumi, Georgia

David Gagua Clinic; 🇬🇪 Tbilisi, Georgia

City Policlinic #17; 🇰🇿 Almaty, Kazakhstan